Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Third Rock Ventures III, L.P. Insider Profile
4 Followers
Third Rock Ventures III, L.P., Ten Percent Owner at Global Blood Therapeutics, holds 2.29M shares in Global Blood Therapeutics (Ticker: GBT), holds 9.93M shares in Revolution Medicines (Ticker: RVMD), holds 5.42M shares in Nurix Therapeutics (Ticker: NRIX). Most recently, Third Rock Ventures III, L.P. ― shares of Global Blood Therapeutics on ― for an estimated value of ―.
Third Rock Ventures III, L.P. Global Blood Therapeutics (GBT)Ten Percent Owner
Global Blood Therapeutics (GBT)
Ten Percent Owner
Ranked #31,921 out of 78,255 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+19.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Third Rock Ventures III, L.P.'s holdings
Insider Roles
Roles that Third Rock Ventures III, L.P. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 22, 2019 - Jul 22, 2020
Return:+39.20%
The most profitable trade made by Third Rock Ventures III, L.P.
Third Rock Ventures III, L.P.'s Trading History
Global Blood Therapeutics
―
Ten Percent Owner
―
$120.59M
Editas Medicine
Aug 16, 2016
Ten Percent Owner
Uninformative Sell
―
$117.15M
Voyager Therapeutics
Sep 19, 2018
Ten Percent Owner
Uninformative Sell
―
$64.71M
MyoKardia
Jan 05, 2018
Ten Percent Owner
Informative Sell
34.29M
$127.32M
Fulcrum Therapeutics
Jul 22, 2019
Ten Percent Owner
Informative Buy
1.30M
$45.55M
Revolution Medicines
Sep 11, 2020
Ten Percent Owner
Uninformative Sell
―
$276.64M
Pliant Therapeutics
Jun 09, 2020
Ten Percent Owner
Uninformative Buy
―
$209.03M
Relay Therapeutics
Jul 21, 2020
Ten Percent Owner
Uninformative Buy
―
$449.89M
Nurix Therapeutics
Jul 29, 2020
Ten Percent Owner
Uninformative Buy
―
$161.65M
List of latest transactions for each holding click on a transaction to see Third Rock Ventures III, L.P.'s performance on stock
You May Also Like
Third Rock Ventures III, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Third Rock Ventures III, L.P.?
The percentage of profitable transactions made by Third Rock Ventures III, L.P. is 50%.
What is the average return per transaction made by Third Rock Ventures III, L.P.?
The average return per transaction made by Third Rock Ventures III, L.P. is 19.60%.
What stocks does Third Rock Ventures III, L.P. hold?
Third Rock Ventures III, L.P. holds: GBT, EDIT, VYGR, MYOK, FULC, RVMD, PLRX, RLAY, NRIX stocks.
What was Third Rock Ventures III, L.P.’s latest transaction?
Third Rock Ventures III, L.P. latest transaction was an Uninformative Buy of ―.
What was Third Rock Ventures III, L.P.'s most profitable transaction?
Third Rock Ventures III, L.P.’s most profitable transaction was an Informative Buy of FULC stock on July 22, 2019. The return on the trade was 39.20%.
What is Third Rock Ventures III, L.P.'s role in Global Blood Therapeutics?
Third Rock Ventures III, L.P.'s role in Global Blood Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.